… make it to pharmacy shelves. Most potential treatments die early, unable to secure the necessary support from the pharmaceutical industry to move research from the laboratory to the clinic. A key part of … announced critical follow-on funding to forward work into novel Parkinson’s treatments.  Jeff Conn, PhD, of …

… and many people with Parkinson’s experience it after diagnosis. The Foundation’s landmark study, the Parkinson’s … focusing on the positive. I decided I would participate in research. Once I retired as an architect, I immediately … lot about the disease. That will help me start managing it early on, which can contribute to things going better over …

… , a “daringly funny and provocative one-man show about early onset Parkinson’s disease.” Marc, a former Seinfeld … this play based on how his life has changed since Karen’s diagnosis. Here is a preview of the show: “Phil is a …

… but it likely starts about 20 years earlier. During this early stage, the disease is hard to diagnose because it can … an early-onset form of the disease. These models are useful research tools because they can be used as a model of the … disease in rats and to make inferences to humans. Impact on Diagnosis/Treatment of Parkinson’s disease:  Findings from …

… The Research Alliances intern helps to define and document our … Now About Us: The Michael J. Fox Foundation for Parkinson’s Research (MJFF) was founded in 2000 with one clear … organization. Since inception, MJFF has quickly grown into the largest nonprofit funder of Parkinson’s disease …

… need for fit-for-purpose, clinical outcome assessments for early-stage Parkinson’s disease (PD) to be used in clinical … relevant to people with PD in the first three years after diagnosis. Study Design:  This study will be conducted in … of Parkinson’s disease:  The project will impact PD research and treatment protocols by providing questionnaires …